Ministry of Health: Drug prices will not fall by more than 10% in 2017 -
The price of medicines in 2017 can not lower more than 10% in relation to the current cost, according to an exceptional mechanism created by the Ministry of Health.
According to an ordinance published yesterday in Diário da República, which determines the annual price review, Spain, France and Italy become the countries to consider for approval of the new prices in 2017.
In 2016, the reference countries were Spain, France and Slovakia.
The brake on the fall in the price of medicinal products is aimed at 'a certain balance in the price revision with regard to large reductions that may occur, corresponding to the commitments entered into by the government in the Pharmaceutical Industry Agreement for 2017' , According to the order cited by "Lusa news agency".
AIn addition to this exceptional mechanism, the annual review of the maximum retail price of generic medicines will also be suspended in 2017, as well as the annual review of the maximum purchase prices of generic medicines by the National Health Service (NHS) establishments and services.
Another ordinance also published yesterday in Diário da República on the price revision says that drugs that are in wholesale distributors and pharmacies, marked with the old price on the day before the entry into force of the new prices may be sold with that Price for 30 days (wholesale distributors) and 60 days (in the case of pharmacies).
Source: "Netfarma" website and author on November 16, 2016